论文部分内容阅读
1986年以来我们对不能手术的食管中段痛20例采用同期缩野每天两次放射治疗，（ConcomitantBoostRadiotherapySobed－ulesasSecondDallyTreatment下简称CBRSSDT）现将5年疗效报告如下：20例中男性16例、女《例，年龄为32～60岁，中位年龄52岁。病变长＜5cmZ例，＜7cmls例，其中
Since 1986, 20 cases of inoperable esophageal middle pain have been treated twice a day with shrinkage twice daily. (ConcomitantBoostRadiotherapySobed-ulesasSecondDallyTreatment referred to as CBRSSDT) is now reported as follows: 20 cases of males and 16 cases of females. The age ranged from 32 to 60 years and the median age was 52 years. Length of lesion <5cmZ, <7cmls, including